Role of dietary salt in hypertension

被引:86
作者
Haddy, Francis J. [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55901 USA
关键词
salt; hypertension; diet; ouabain;
D O I
10.1016/j.lfs.2006.05.017
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Certain things have not changed since my colleague and I last reviewed the role of dietary salt in hypertension [Haddy, F.J., Pamnani, M.B., 1995. Role of dietary salt in hypertension. Journal of the American College of Nutrition 14, 428-438]. Over half of hypertensives are still salt sensitive, i.e., they respond to a high NaCl intake with a rise in blood pressure. This can be ameliorated by restricting NaCl intake, supplementing potassium intake, and consuming diuretics. Some things have changed. We now have more insight into mechanism; we suspected that volume expansion and endogenous Na+,K+-ATPase inhibitors were the connection between excessive salt intake and the hypertension, but we were not certain as to the nature of the inhibitors. Now it appears that the inhibitors are steroids released from the adrenal gland and are members of the cardenolide family, e.g., ouabain, and the bufadienolide family, e.g., marinobufagenin. This presents new possibilities in therapy, including antibodies to these agents and competitive inhibitors to their binding to Na+,K+-ATPase. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1585 / 1592
页数:8
相关论文
共 105 条
[1]  
Adair CD, 1996, AM J NEPHROL, V16, P529
[2]   INCREASED INTRA-LYMPHOCYTIC SODIUM CONTENT IN ESSENTIAL-HYPERTENSION - AN INDEX OF IMPAIRED NA+ CELLULAR-METABOLISM [J].
AMBROSIONI, E ;
COSTA, FV ;
MONTEBUGNOLI, L ;
TARTAGNI, F ;
MAGNANI, B .
CLINICAL SCIENCE, 1981, 61 (02) :181-186
[3]   Endogenous marinobufagenin-like immunoreactive substance - A possible endogenous Na,K-ATPase inhibitor with vasoconstrictor activity [J].
Bagrov, AY ;
Dmitrieva, RI ;
Fedorova, OV ;
Kazakov, GP ;
Roukoyatkina, NI ;
Shpen, VM .
AMERICAN JOURNAL OF HYPERTENSION, 1996, 9 (10) :982-990
[4]   Cardenolide and bufadienolide ligands of the sodium pump. How they work together in NaCl sensitive hypertension [J].
Bagrov, AY ;
Fedorova, OV .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 :2250-2256
[5]   Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction [J].
Bagrov, AY ;
Fedorova, OV ;
Dmitrieva, RI ;
Howald, WN ;
Hunter, AP ;
Kuznetsova, EA ;
Shpen, VM .
HYPERTENSION, 1998, 31 (05) :1097-1103
[6]  
Bagrov AY, 1996, CARDIOVASC RES, V31, P296
[7]   Endogenous digitalis-like ligands and Na/K-atpase inhibition in experimental diabetes mellitus [J].
Bagrov, YY ;
Manusova, NB ;
Egorova, IA ;
Fedorova, OV ;
Bagrov, AY .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 :2257-2262
[8]   PHYSIOLOGICAL-EFFECTS OF ENDOGENOUS OUABAIN - CONTROL OF INTRACELLULAR CA-2+STORES AND CELL RESPONSIVENESS [J].
BLAUSTEIN, MP .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (06) :C1367-C1387
[9]   SODIUM IONS, CALCIUM-IONS, BLOOD-PRESSURE REGULATION, AND HYPERTENSION - REASSESSMENT AND A HYPOTHESIS [J].
BLAUSTEIN, MP .
AMERICAN JOURNAL OF PHYSIOLOGY, 1977, 232 (05) :C165-C173
[10]   Endogenous digitalis-like factors. An historical overview [J].
Buckalew, VM .
FRONTIERS IN BIOSCIENCE, 2005, 10 :2325-2334